论文部分内容阅读
目的:探讨卵巢交界性肿瘤的临床特点及治疗方法。方法:回顾分析9年间收治的BOT患者共39例。结果:35例随访至终点的病例中死亡1例,死亡率2.9%。复发5例,复发率14.7%,其中Ia期1例,Ib期1例,Ic期2例,Ⅲ期1例。复发病例中浆液性3例,1例同时有微乳头结构及微浸润。6例肿瘤剥除者中3例复发,18例单侧附件切除者中1例复发。结论:不同FIGO分期是卵巢交界性肿瘤复发的影响因素。手术是卵巢交界性肿瘤的主要治疗方法,早期有生育要求的患者可选择保守性手术,并尽量选择附件切除术;晚期患者宜行根治性手术。
Objective: To investigate the clinical features and treatment of borderline ovarian tumors. Methods: A retrospective analysis of 39 patients with BOT treated in 9 years. Results: Among the 35 patients who were followed up to the end point, 1 died and the mortality rate was 2.9%. Recurrence in 5 cases, the recurrence rate was 14.7%, including 1 case of Ia, Ib in 1 case, Ic in 2 cases, and in 1 case. Three cases of serous recurrence, one case with micro-nipple structure and micro-infiltration. Three of the six tumor strokes relapsed, and one of 18 unilateral excision patients relapsed. Conclusion: Different FIGO staging is the influencing factor of borderline ovarian tumor recurrence. Surgery is the main treatment of borderline ovarian tumors, early reproductive patients may choose conservative surgery, and try to choose the attachment resection; advanced patients should undergo radical surgery.